Granry-AM Tablet
230,00 ₹
Analogs of Granry-AM Tablet
Find cheaper analogs and generic equivalents for Granry-AM Tablet.
ਸਰਗਰਮ ਤੱਤ: Irbesartan; Chlorthalidone
ਉਤਪਾਦ ਝਲਕ
About Granry-AM Tablet
Granry-AM Tablet is a medication containing the active ingredient irbesartan, classified as Angiotensin 2 Receptor Blocker. Irbesartan, sold under the brand name Aprovel among others, is a medication used to treat hypertension, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination irbesartan/hydrochlorothiazide.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE Irbesartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood.
- Used for: Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
irbesartan, the active ingredient in Granry-AM Tablet, belongs to the Angiotensin 2 Receptor Blocker class. 1 INDICATIONS AND USAGE Irbesartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Granry-AM Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Granry-AM Tablet for extended periods without medical advice.
Find in Pharmacies
Compare local prices and distance for Granry-AM Tablet.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.